Pharmocann Global Dividend
Dividend criteria checks 0/6
Pharmocann Global does not have a record of paying a dividend.
Key information
n/a
Dividend yield
31.5%
Buyback Yield
| Total Shareholder Yield | 31.5% |
| Future Dividend Yield | n/a |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | n/a |
Recent dividend updates
No updates
Recent updates
The Returns On Capital At Pharmocann Global (TLV:PMCN) Don't Inspire Confidence
Mar 30
Should You Use Pharmocann Global's (TLV:PMCN) Statutory Earnings To Analyse It?
Feb 04Pharmocann Global Ltd (TLV:PMCN) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
Dec 31
The Returns At Pharmocann Global (TLV:PMCN) Provide Us With Signs Of What's To Come
Nov 26Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if PMCN-M's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if PMCN-M's dividend payments have been increasing.
Dividend Yield vs Market
| Pharmocann Global Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (PMCN-M) | n/a |
| Market Bottom 25% (IL) | 2.4% |
| Market Top 25% (IL) | 6.5% |
| Industry Average (Pharmaceuticals) | 1.8% |
| Analyst forecast (PMCN-M) (up to 3 years) | n/a |
Notable Dividend: Unable to evaluate PMCN-M's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate PMCN-M's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate PMCN-M's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as PMCN-M has not reported any payouts.